Pulmicort Sterile 0.5mg/ml Budesonide Nebulizing Suspension, 20x2ml

Pulmicort Nebulizing Suspension contains Budesonide, an inhaled corticosteroid (ICS) formulated for delivery via a nebulizer. Budesonide reduces airway inflammation by suppressing the inflammatory mediators responsible for bronchial oedema, mucus hypersecretion, and airway hyperresponsiveness in asthma and COPD. The nebulizer delivery route is used for patients who cannot coordinate a pressurized metered-dose inhaler effectively - including young children, infants, and patients during acute exacerbations. The sterile single-dose ampoule design ensures each dose is delivered from an uncontaminated, precisely measured unit.

Specs

• Active ingredient: Budesonide 0.5mg/ml
• Form: Sterile nebulizing suspension in single-dose ampoules
• Pack size: 20 ampoules x 2ml
• Drug class: Inhaled corticosteroid (ICS)
• Indication: Asthma / COPD maintenance
• Prescription: Required

Benefits

• Budesonide's potent topical anti-inflammatory action in the airways reduces the eosinophilic and mast cell infiltration, epithelial damage, and mucus gland hypertrophy that characterize chronic asthma - preventing the airway remodelling that leads to progressive, irreversible airflow limitation if inflammation is inadequately controlled
• Nebulized delivery deposits the corticosteroid directly in the airways without requiring patient coordination of inhalation and actuation, making it particularly effective for young children with asthma who cannot use standard inhalers, and for acute exacerbation management in hospital settings
• The sterile single-dose ampoule format eliminates the contamination risk associated with multi-dose liquid nebulizer preparations, and the precise 2ml volume per ampoule ensures consistent dose delivery at each nebulization session
• Pulmicort's extensive clinical evidence base - from randomized controlled trials in infant asthma through to adult COPD - provides the strongest pharmacovigilance foundation of any nebulized corticosteroid preparation
• Regular preventive use reduces exacerbation frequency, acute hospital admissions, and the need for systemic corticosteroid courses - delivering clinical and economic benefits that establish ICS maintenance as the cornerstone of asthma management

How to Use

• Use only as prescribed by your physician - dose and frequency depend on age, severity, and specific indication
• Open one ampoule immediately before use and pour the entire contents into the nebulizer cup
• Assemble the nebulizer according to the manufacturer's instructions
• Breathe normally through the mouthpiece or mask until the treatment is complete - typically 5 to 10 minutes
• Rinse the mouth with water after nebulization to reduce the risk of oral candidiasis from corticosteroid deposition
• Discard unused suspension from opened ampoules - single-use only
• Clean and disinfect the nebulizer after each use according to manufacturer guidance
• Never inject Pulmicort or administer by any route other than inhalation via a suitable nebulizer